Paul Hargreaves
Corporate Officer/Principal at SPAGO NANOMEDICAL AB
Profile
Paul Hargreaves is currently the Chief Development Officer at Spago Nanomedical AB since 2021.
Prior to this, he worked at LEO Pharma.
A as the Head-Global Clinical Operations & Vice President.
Paul Hargreaves active positions
Companies | Position | Start |
---|---|---|
SPAGO NANOMEDICAL AB | Corporate Officer/Principal | 12/09/2021 |
Former positions of Paul Hargreaves
Companies | Position | End |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPAGO NANOMEDICAL AB | Health Technology |
Private companies | 1 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Paul Hargreaves